Ubisoft, Warner Music Group, Intel Capital and Liberty Technology Venture Capital helped the game development platform provider secure $52.5m.

Madryn Asset Management has provided debt and equity financing intended to help Abbott-backed Bigfoot Biomedical bring its diabetes management technology to market.

VIB’s antiviral treatment developer has closed its series A round following a $22.6m extension backed by the research institute, V-Bio Ventures and Vives Inter-University Fund.

UCB’s corporate venture capital unit has helped the antiviral treatment developer close its series A round, joining a $22.6m extension.

Sunac Services supplied the lion's share of the capital for the smart home device producer's series A round, which has closed at approximately $76.9m.

Insight Partners and Scale Venture Partners co-led a series C round for the GV-backed stroke detection software provider, taking its total funding to $150m.

Falcon Edge Capital has led the latest round for the Info Edge, Intel, SoftBank and Tencent-backed online insurance marketplace operator.

Eli Lilly and Novartis Venture Fund participated in a round that will support the progress of Amphista's protein degradation drug candidates toward clinical trials.

The SoftBank and Baidu-backed agricultural drone developer has pulled in series C-plus-plus funding from Hillhouse Capital's GL Ventures fund.

Forbion and Gilde Healthcare have co-led a $53m series B round for Dundee spinout Amphista, which is working on targeted protein degradation technology.